Related Experiment Video
Updated: Jan 27, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Improved in vivo targeting of BCL-2 phenotypic conversion through hollow gold nanoshell delivery
Erin Morgan1, John T Gamble2, Martin C Pearce2
1Department of Chemistry and Biochemistry, University of California, Santa Barbara, CA, USA. emorgan@chem.ucsb.edu.
Abstract:
Although new cancer therapeutics are discovered at a rapid pace, lack of effective means of delivery and cancer chemoresistance thwart many of the promising therapeutics. We demonstrate a method that confronts both of these issues with the light-activated delivery of a Bcl-2 functional converting peptide, NuBCP-9, using hollow gold nanoshells. This approach has shown not only to increase the efficacy of the peptide 30-fold in vitro but also has shown to reduce paclitaxel resistant H460 lung xenograft tumor growth by 56.4%.
Insights
This study introduces a novel light-activated drug delivery system using hollow gold nanoshells to deliver a peptide, enhancing cancer therapy efficacy and overcoming chemoresistance in lung cancer models.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapeutics
Background:
- Developing effective cancer therapeutics faces challenges in drug delivery and chemoresistance.
- Targeted delivery systems are crucial for improving treatment outcomes.
- Bcl-2 proteins play a role in cancer cell survival.
Purpose of the Study:
- To develop a light-activated delivery method for a Bcl-2 functional converting peptide (NuBCP-9).
- To address limitations of current cancer therapeutics, including delivery and chemoresistance.
- To evaluate the efficacy of NuBCP-9 delivered via hollow gold nanoshells.
Main Methods:
- Utilized hollow gold nanoshells for light-activated drug delivery.
- Employed a Bcl-2 functional converting peptide, NuBCP-9.
- Tested the system in vitro and in a paclitaxel-resistant H460 lung xenograft model.
Main Results:
- Achieved a 30-fold increase in peptide efficacy in vitro.
- Demonstrated a 56.4% reduction in paclitaxel-resistant H460 lung xenograft tumor growth.
- Validated the dual action of enhanced delivery and overcoming chemoresistance.
Conclusions:
- Light-activated delivery of NuBCP-9 using hollow gold nanoshells is a promising strategy for cancer treatment.
- This method effectively enhances therapeutic efficacy and combats chemoresistance.
- The approach holds potential for improving outcomes in challenging cancer cases.
More Related Videos
09:23Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
Published on: October 10, 2025
10:38Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery
Published on: January 15, 2018
Related Concept Videos
Gene Conversion
Gene Conversion
Thin-Walled Hollow Shafts
Conversion of Units
The first step in the unit conversion is to list the given units and the units required...
Conversion of Alcohols to Alkyl Halides
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H